Literature DB >> 20011304

Management of hepatic metastases from colorectal cancer.

Ketan R Sheth1, Bryan M Clary.   

Abstract

The majority of hepatic metastases in the United States occur in patients with a primary colorectal malignancy. Advances in technology combined with increasing surgeon experience have broadened the treatment options available for hepatic metastases from colorectal cancer. Surgical resection is the most effective therapy for metastatic colorectal cancer isolated to the liver. The aim of this article is to discuss the role of locally aggressive treatment options including resection, ablation, and regional chemotherapy in the management of patients with metastases from colorectal cancer.

Entities:  

Keywords:  Hepatic metastases; colorectal cancer; hepatic ablation; hepatic resection

Year:  2005        PMID: 20011304      PMCID: PMC2780092          DOI: 10.1055/s-2005-916282

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  55 in total

1.  Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver.

Authors:  Robert C G Martin; Michael J Edwards; Kelly M McMasters
Journal:  Am J Surg       Date:  2004-12       Impact factor: 2.565

2.  Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.

Authors:  S A Curley; F Izzo; L M Ellis; J Nicolas Vauthey; P Vallone
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

3.  Liver resection for colorectal metastases.

Authors:  Y Fong; A M Cohen; J G Fortner; W E Enker; A D Turnbull; D G Coit; A M Marrero; M Prasad; L H Blumgart; M F Brennan
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

4.  Detection of liver metastases from colorectal cancer: comparison of intraoperative US and CT during arterial portography.

Authors:  P Soyer; M Levesque; D Elias; G Zeitoun; A Roche
Journal:  Radiology       Date:  1992-05       Impact factor: 11.105

5.  Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history.

Authors:  J Scheele; R Stangl; A Altendorf-Hofmann
Journal:  Br J Surg       Date:  1990-11       Impact factor: 6.939

6.  Hepatic resection for colorectal metastases: analysis of prognostic factors.

Authors:  S Ambiru; M Miyazaki; T Isono; H Ito; K Nakagawa; H Shimizu; K Kusashio; S Furuya; N Nakajima
Journal:  Dis Colon Rectum       Date:  1999-05       Impact factor: 4.585

7.  Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications.

Authors:  T F Wood; D M Rose; M Chung; D P Allegra; L J Foshag; A J Bilchik
Journal:  Ann Surg Oncol       Date:  2000-09       Impact factor: 5.344

8.  A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma.

Authors:  C J Lahr; S J Soong; G Cloud; J W Smith; M M Urist; C M Balch
Journal:  J Clin Oncol       Date:  1983-11       Impact factor: 44.544

9.  Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis.

Authors:  Robert Martin; Philip Paty; Yuman Fong; Andrew Grace; Alfred Cohen; Ronald DeMatteo; William Jarnagin; Leslie Blumgart
Journal:  J Am Coll Surg       Date:  2003-08       Impact factor: 6.113

10.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

View more
  39 in total

Review 1.  Multidisciplinary management in rectal cancer.

Authors:  Asunción Hervás Morón; María Luisa García de Paredes; Eduardo Lobo Martínez
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

2.  Apoptotic effect of genistein on human colon cancer cells via inhibiting the nuclear factor-kappa B (NF-κB) pathway.

Authors:  Yi Luo; Sheng-xiang Wang; Ze-quan Zhou; Zheng Wang; Yan-gao Zhang; Yu Zhang; Peng Zhao
Journal:  Tumour Biol       Date:  2014-08-16

Review 3.  An Overview of the Current Management of Bilobar Colorectal Liver Metastases.

Authors:  Rebecca K L Griggs; Samir Pathak; Graeme Poston
Journal:  Indian J Surg Oncol       Date:  2017-08-09

4.  Enhanced colorectal cancer metastases in the alcohol-injured liver.

Authors:  Ashley M Mohr; John J Gould; Jacy L Kubik; Geoffrey A Talmon; Carol A Casey; Peter Thomas; Dean J Tuma; Benita L McVicker
Journal:  Clin Exp Metastasis       Date:  2017-02-06       Impact factor: 5.150

5.  The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells.

Authors:  Melania E Mercado-Pimentel; Benjamin C Onyeagucha; Qing Li; Angel C Pimentel; Jana Jandova; Mark A Nelson
Journal:  FEBS Lett       Date:  2015-07-17       Impact factor: 4.124

6.  Hepatic arterial infusion pump chemotherapy for colorectal liver metastases: an old technology in a new era.

Authors:  Y J Ko; P J Karanicolas
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

7.  First-line treatment with hepatic arterial infusion plus capecitabine vs capecitabine alone for elderly patients with unresectable colorectal liver metastases.

Authors:  Xiaodong Li; Liangrong Shi; Jun Wu; Mei Ji; Jiemin Zhao; Weiguang Qiang; Wenge Ding; Jingting Jiang; Qicheng Lu; Changping Wu
Journal:  Cancer Biol Ther       Date:  2016       Impact factor: 4.742

Review 8.  Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis.

Authors:  Thomas D Vreugdenburg; Ning Ma; Joanna K Duncan; Dagmara Riitano; Alun L Cameron; Guy J Maddern
Journal:  Int J Colorectal Dis       Date:  2016-09-29       Impact factor: 2.571

9.  Association Between Coffee Intake After Diagnosis of Colorectal Cancer and Reduced Mortality.

Authors:  Yang Hu; Ming Ding; Chen Yuan; Kana Wu; Stephanie A Smith-Warner; Frank B Hu; Andrew T Chan; Jeffrey A Meyerhardt; Shuji Ogino; Charles S Fuchs; Edward L Giovannucci; Mingyang Song
Journal:  Gastroenterology       Date:  2017-11-20       Impact factor: 22.682

10.  S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer.

Authors:  Benjamin Chidi Onyeagucha; Melania E Mercado-Pimentel; Jennifer Hutchison; Erik K Flemington; Mark A Nelson
Journal:  Exp Cell Res       Date:  2013-05-18       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.